ReproCELL Incorporated (TYO:4978)
181.00
+3.00 (1.69%)
Aug 29, 2025, 1:43 PM JST
ReproCELL Market Cap
ReproCELL has a market cap or net worth of 16.85 billion as of August 28, 2025. Its market cap has increased by 48.48% in one year.
Market Cap
16.85B
Enterprise Value
12.14B
Revenue
2.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
181.00
Market Cap Chart
Since June 27, 2013, ReproCELL's market cap has decreased from 145.35B to 16.85B, a decrease of -88.40%. That is a compound annual growth rate of -16.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 16.85B | 71.99% |
Dec 30, 2024 | 9.80B | -34.19% |
Dec 29, 2023 | 14.89B | -42.13% |
Dec 30, 2022 | 25.73B | 35.26% |
Dec 30, 2021 | 19.02B | -35.21% |
Dec 30, 2020 | 29.36B | 94.87% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 10.66T |
Takeda Pharmaceutical Company | 6,921.19B |
Daiichi Sankyo Company | 6,648.58B |
HOYA Corporation | 6,598.19B |
Otsuka Holdings | 4,139.49B |
Terumo | 3,928.07B |
Astellas Pharma | 2,900.30B |
Shionogi & | 2,178.95B |